SHP Wealth Management’s Day One Biopharmaceuticals DAWN Stock Holding History

SHP Wealth Management’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-25	Closed	-$536	–	2009
2026 Q1	$536	Buy	+25	New	+$352	﹤0.01%	1607

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SHP Wealth Management's DAWN Position: Q2 2026 in Review

SHP Wealth Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 25 shares — an estimated $536 sold.

SHP Wealth Management first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $536 in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

SHP Wealth Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
SHP Wealth Management sold 25 Day One Biopharmaceuticals shares in Q2 2026, an estimated $536.
SHP Wealth Management first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
SHP Wealth Management's Day One Biopharmaceuticals position peaked at $536 in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on SHP Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.